BfArM approvals from DCP procedure for Rivastigmin patches granted for Germany, Austria, Romania, Sweden, Slovakia and the Czech Republic

On August 28, 2015, the BfArM received approvals from the DCP process for rivastigmine patches in the dosages 4.6 mg / 24 h and 9.5 mg / 24 h for the countries Germany, Austria, Romania, Sweden, Slovakia and the Czech Republic granted.